0001127602-15-016605.txt : 20150507 0001127602-15-016605.hdr.sgml : 20150507 20150507204539 ACCESSION NUMBER: 0001127602-15-016605 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150507 FILED AS OF DATE: 20150507 DATE AS OF CHANGE: 20150507 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROTHBLATT MARTINE A CENTRAL INDEX KEY: 0001106578 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 15843736 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2015-05-07 0001082554 UNITED THERAPEUTICS Corp UTHR 0001106578 ROTHBLATT MARTINE A C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910 1 1 Chairman & Co-CEO Common Stock 2015-05-07 4 M 0 4115 34.56 A 4355 D Common Stock 2015-05-07 4 S 0 4115 168.1758 D 240 D Common Stock 2015-05-07 4 M 0 5547 30.75 A 5787 D Common Stock 2015-05-07 4 S 0 200 166.03 D 5587 D Common Stock 2015-05-07 4 S 0 900 167.5477 D 4687 D Common Stock 2015-05-07 4 S 0 200 168.335 D 4487 D Common Stock 2015-05-07 4 S 0 656 170.8567 D 3831 D Common Stock 2015-05-07 4 S 0 400 171.6425 D 3431 D Common Stock 2015-05-07 4 S 0 1100 173.1536 D 2331 D Common Stock 2015-05-07 4 S 0 1291 173.927 D 1040 D Common Stock 2015-05-07 4 S 0 800 169.6538 D 240 D Common Stock 166 I By Spouse Common Stock 625031.05 I By Trusts Stock Options 34.56 2015-05-07 4 M 0 4115 0 D 2005-12-30 2015-12-30 Common Stock 4115 115235 D Stock Options 30.75 2015-05-07 4 M 0 5547 0 D 2009-12-26 2017-12-31 Common Stock 5547 477007 D This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009. This transaction was executed in multiple trades at prices ranging from $167.78 to $168.595. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $165.57 to $166.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $167.10 to $168.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $168.23 to $168.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $170.32 to $171.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $171.36 to $172.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $172.55 to $173.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $173.59 to $173.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $169.31 to $170.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Adjusted to reflect a total of 30,644 shares originally acquired by the reporting person on 4/27/15 and 5/4/15 pursuant to "exercise and hold" transactions, which were then transferred into trusts beneficially owned by the reporting person. Adjusted to reflect a total of 30,644 shares originally acquired by the reporting person on 4/27/15 and 5/4/15 pursuant to "exercise and hold" transactions, which were then transferred into trusts beneficially owned by the reporting person. /s/ John S. Hess, Jr. under Power of Attorney 2015-05-07